Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, ...

The Global AI in Precision Medicine Market is expected to witness a growth rate of 25-30% in the next five ...

The Global Metaverse in Medical Training Market is expected to witness a growth rate of 8-9% in the next five years. Enhanced ...

The global Infusion Pump Market is valued at USD 17.99 billion in 2024 and is projected to reach a value of USD 31.56 billion ...

Responding to Dr Penny Dash’s review of patient safety across the health and care landscape, Matthew Taylor, chief executive of the NHS Confederation, said: “Patient empowerment is crucial to the ...

The AI in Life Science Market is anticipated to experience a remarkable compound annual growth rate (CAGR) of around 25% in the coming years, highlighting the increasing reliance on AI technologies ...

Live-In Care is the Solution to England’s Discharge CrisisAs NHS hospitals continue to face serious pressure from delayed discharges, Noble Live-In Care is calling for live-in care to be routinely ...

First patient dosed in the Phase I clinical trial of PulseSight Therapeutics’ PST-611 treatment for dry AMD/Geographic AtrophyParis, France, July 7th, 2025 – PulseSight Therapeutics SAS, an ...

Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on difficult-to-treat cancers, today announces that its drug Pepaxti has been included in new clinical practice guidelines ...

OncoZenge Appoints Tuulikki Lindmark as Head of CMC in Phase 3 Sponsor TeamOncoZenge AB (publ) ("OncoZenge" or "the Company") announces today that the sponsor team for the phase 3 project with ...

UCB’s continued commitment to leading research aimed at improving treatment outcomes for people living with neurological conditions.Data include the use of FINTEPLA®▼ (fenfluramine)1 in Dravet ...

FAYETTEVILLE, ARKANSAS / ACCESS Newswire / July 7, 2025 / With around 30 million children participating in organized sports ...